← Leaderboards
Sarah Jean Nechuta
Vanderbilt University
$419,205
Attributed
$419,205
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135.8K · FY2013–16$200K$150K$100K$50K$0
'13
'14
'15
'16
Funding mix
By agency
NIH$419,205 · 2
By mechanism
K07$265,545 · 1
R03$153,660 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Jennifer A Pietenpol$43,416,854
- David K Cortez$25,955,406
- Walter J Chazin$29,538,014
- Chin Chiang$11,458,845
- Carlos L Arteaga$27,881,034
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorBiologicalLifestyle FactorsTriple-Negative Invasive Breast CarcinomaProspective StudiesMalignant Breast NeoplasmCohort StudiesLeadMorbidity - Disease RateRecurrenceAffectCancer RecurrenceCancer SurvivorOutcome ForecastBreastCohortDesignFutureCancer SurvivorshipCancer TherapyCancer CareCareerChemotherapyCancer Biology
Grant awards (5)
DNA Repair Pathways in Triple Negative Breast Cancer Outcomes$124,498
K07 · FY2016 · CA · contact PI
DNA Repair Pathways in Triple Negative Breast Cancer Outcomes$11,316
K07 · FY2016 · CA · contact PI
DNA Repair Pathways in Triple Negative Breast Cancer Outcomes$129,731
K07 · FY2015 · CA · contact PI
Modifiable lifestyle-related factors and triple negative breast cancer prognosis$75,660
R03 · FY2014 · CA · contact PI
Modifiable lifestyle-related factors and triple negative breast cancer prognosis$78,000
R03 · FY2013 · CA · contact PI